ADAR1 Capital Management »

Kazia Therapeutics shares owned by ADAR1 Capital Management

Quarter-by-quarter ownership of Kazia Therapeutics (KZIA) shares owned by ADAR1 Capital Management from 13F filings

Historical chart of ADAR1 Capital Management investment in Kazia Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Kazia Therapeutics held by ADAR1 Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Kazia Therapeutics by ADAR1 Capital Management

Quarter filed Position value Share count Share price at filing
2026-06-30 $867k 62k 14.08

More positions owned by ADAR1 Capital Management

Abivax Sa Sponsored Ads (ABVX)
Protagonist Therapeutics (PTGX)
State Str Spdr S&p 500 Etf T Tr Unit Put Option (SPY)
Roivant Sciences SHS (ROIV)
Immunovant (IMVT)
Zai Lab Adr (ZLAB)
Agios Pharmaceuticals (AGIO)
Crinetics Pharmaceuticals In (CRNX)
Ea Series Trust Alpha Arch 1-3 (BOXX)
Cytokinetics Com New (CYTK)
Septerna (SEPN)
Anteris Technologies Global (AVR)
Editas Medicine (EDIT)
Denali Therapeutics (DNLI)
Spyre Therapeutics Com New (SYRE)

View all positions for ADAR1 Capital Management

Top funds holding Kazia Therapeutics

Boxer Capital Management
Putnam Fl Investment Management
Bleichroeder
Ikarian Capital
Dauntless Investment Group
Stonepine Capital Management
Susquehanna International
Point72 Asset Management
Ensign Peak Advisors
Citadel Advisors
Millennium Management
Jane Street
UBS Group
J. Goldman & Co
ADAR1 Capital Management

View all funds holding Kazia Therapeutics